Collectively, these data demonstrate that NSUN2 establishes CDS-specific m5C marks on LGR4 mRNA to enable ALYREF recognition, thereby promoting cisplatin resistance in ovarian cancer. Here, NSUN2 is linked to ovarian carcinoma.